AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...

The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.

The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

The integration of genomics into the pharmaceutical industry has allowed researchers to better understand the genetic factors ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Research from Vibrant Sciences, confirming high sensitivity and broad pathogen coverage using low-volume antibody testing, published in Nature SANTA CLARA, CA / ACCESS Newswire / May 13, 2025 / A new ...

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

Namibia recorded 5,921 new malaria cases and eight deaths between May 5 and 11, marking a 12-percent decrease from the ...